PD-1 Blockade Plus Chemoradiotherapy As Preoperative Therapy for Patients with BRPC/LAPC: A Biomolecular Exploratory, Phase II Trial

Investigators detailed findings from a phase II study of PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with locally advanced or borderline resectable pancreatic cancer. Twenty-nine patients were enrolled in the study.